Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ligand Innovation Global is a private Canadian health technology and medical device company developing low-cost automated resuscitation and ventilation devices for resource-limited healthcare settings. Its lead product is the VitaCaeli, also referred to as the VitaCaeli G1 or LifeAir G1, a portable electromechanical bag-valve-mask automation device intended to provide controlled intermittent positive pressure ventilation. The company positions itself as a social enterprise focused on improving resuscitation care, especially in developing countries where conventional mechanical ventilators are expensive and scarce. Publicly available materials emphasize prototype development, patent activity, and commercial/distribution relationships rather than an FDA-cleared or broadly commercialized product portfolio. The business appears to be private, Canada-based, and partnership-oriented, with backing from Forwardly and support from innovation ecosystem organizations such as Innovation Factory.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ligand Innovation Global.